Skip to main content
Marinus Pharmaceuticals, Inc. (MRNS)
Feb 11, 2025 - MRNS was delisted (reason: acquired by Immedica)
0.550
+0.001 (0.09%)
Inactive · Last trade price on Feb 11, 2025

Marinus Pharmaceuticals Revenue

Marinus Pharmaceuticals had revenue of $8.54M in the quarter ending September 30, 2024, with 16.39% growth. This brings the company's revenue in the last twelve months to $31.47M, up 1.63% year-over-year. In the year 2023, Marinus Pharmaceuticals had annual revenue of $30.99M with 21.63% growth.

Revenue (ttm)
$31.47M
Revenue Growth
+1.63%
P/S Ratio
1.00
Revenue / Employee
$189,554
Employees
166
Market Cap
30.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202330.99M5.51M21.63%
Dec 31, 202225.48M10.13M66.03%
Dec 31, 202115.35M13.63M793.19%
Dec 31, 20201.72M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

MRNS News

More News